Accenture Purchases Defense Point Security in Federal Cyber Expansion Push

cybersecurityAccenture (NYSE: ACN) has agreed to buy Alexandria, Virginia-based cybersecurity company Defense Point Security for an undisclosed amount in a strategy to expand the global consulting firm’s cyber defense platforms and services for federal agencies.

Accenture said Wednesday DPS will operate as a subsidiary within the firm’s Accenture Federal Services organization.

AFS CEO David Moskovitz said the firm seeks to combine its cyber defense platforms and client knowledge with DPS’ experience in security analytics and operational security in an effort to help federal agencies protect their data from cyber threats.

The transaction is subject to closing conditions and regulatory review and is intended to complement Accenture’s acquisitions of Arlington, Virginia-based incident response and adversary simulation services provider FusionX in August 2015 and Houston-based industrial control system security firm Cimation nearly four months later.

DPS works to provide cyber operations, information assurance, cybersecurity training and education, security engineering and architecture and managed security services to government and commercial clients.

You may also be interested in...

a.i. solutions

a.i. solutions Wins Potential $203M MDA Advisory, Assistance Contract

Lanham, Maryland-based a.i. solutions has won a potential five-year, $203.2M contract to advise and assist the Missile Defense Agency on quality and mission assurance matters.

Hawk Carlisle President and CEO NDIA

NDIA Adds 16 Industry Execs to Board; Hawk Carlisle Quoted

Sixteen executives from the private sector have been appointed to serve on the National Defense Industrial Association’s board of directors for a term of up to six years. Herbert “Hawk” Carlisle, president and CEO of NDIA, said in a statement released Monday the new board members bring a “deep knowledge bank” he believes will help the organization sustain its mission while supporting the defense industrial base.